https://orcid.org/0000-0001-9180-575X
Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shataer Aini, Shayiti Bolati, Wei Ding, Siyin Liu, Pengcheng Su, Saiding Aili, Yimin Naman & Kuerban Xuekelaiti. (2022) LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer. Bioengineered 13:5, pages 11430-11439.
Read now
Read now
Chun Wang & Bo Cheng. (2022) MicroRNA miR-3646 promotes malignancy of lung adenocarcinoma cells by suppressing sorbin and SH3 domain-containing protein 1 via the c-Jun NH2-terminal kinase signaling pathway. Bioengineered 13:3, pages 4869-4884.
Read now
Read now
Articles from other publishers (3)
Ran Yang, Jinli Han & Song Zhao. (2023) LINC01082 Inhibits Non-Small Cell Lung Cancer by Targeting the miR-543/TNRC6A Axis. Biochemical Genetics 61:4, pages 1585-1605.
Crossref
Crossref
Nengqian Ma, Zhangzhan Li, Jingting Yan, Xianrong Liu, Liyan He, Ruijie Xie & Xianzhou Lu. (2023) Diverse roles of UBE2T in cancer (Review). Oncology Reports 49:4.
Crossref
Crossref
Huijun Zhou, Chong Zeng, Jie Liu, Haijun Luo & Wei Huang. (2023) F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner. Cancers 15:3, pages 957.
Crossref
Crossref